Alex Ossola

He didn't respond to requests for comment.

And that's what's news for this Thursday afternoon.

Today's show was produced by Pierre Bien-Aimé and Alexis Moore with supervising producer Tali Arbel.

I'm Alex Osola for The Wall Street Journal.

We'll be back with a new show tomorrow morning.

Thanks for listening.

Here's your Midday Brief for Thursday, February 19th.

I'm Alex Ocele for The Wall Street Journal.

Walmart is no longer the country's largest company by revenue after falling behind Amazon for the first time.

That's despite reporting strong growth in the most recent quarter.

The company says U.S.

Here's your midday brief for Wednesday, February 18th.

I'm Alex Osola for The Wall Street Journal.

The Food and Drug Administration has agreed to begin a review of Moderna's new flu shot.

The agency reversed course from earlier this month when it refused to start the review.

Moderna agreed to do additional testing in the elderly.

The FDA is now expected to make a decision by August.

If approved, Moderna's flu shot could become available for the 2026-2027 flu season.

Moderna shares were up more than 5% in midday trading.

New data out today from the Federal Reserve showed that U.S.